{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "East Brunswick",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "88593",
      "recalling_firm": "RISING PHARMACEUTICALS",
      "address_1": "2 Tower Center Blvd",
      "address_2": "",
      "postal_code": "08816-1100",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "to be entered",
      "recall_number": "D-0005-2022",
      "product_description": "Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816, Manufactured by: Aurex laboratories LLC, East Windsor, NJ 08520, NDC 16571-752-01",
      "product_quantity": "1,344 bottles",
      "reason_for_recall": "Labeling: Incorrect Instructions",
      "recall_initiation_date": "20210902",
      "center_classification_date": "20211007",
      "report_date": "20211013",
      "code_info": "Lot # CB21024, Exp 2/2023",
      "more_code_info": ""
    }
  ]
}